The influence of estradiol/follicle and estradiol/oocyte ratios on the outcome of controlled ovarian stimulation for in vitro fertilization
R Orvieto, E Zohav, S Scharf, J Rabinson… - Gynecological …, 2007 - Taylor & Francis
Objective. The aim of the study was to evaluate the influence of the ratios of estradiol (E2) to
either the number of follicles> 14 mm on the day of human chorionic gonadotropin …
either the number of follicles> 14 mm on the day of human chorionic gonadotropin …
Do poor-responder patients benefit from increasing the daily gonadotropin dose during controlled ovarian hyperstimulation for IVF?
J Haas, E Zilberberg, R Machtinger… - Gynecological …, 2015 - Taylor & Francis
We aim to assess the in vitro fertilization-embryo transfer (IVF-ET) outcome in patients
receiving an extremely high 450 daily dose (IU) of gonadotropins during controlled ovarian …
receiving an extremely high 450 daily dose (IU) of gonadotropins during controlled ovarian …
Relationship between the oestradiol/oocyte ratio and the outcome of assisted reproductive technology cycles with gonadotropin releasing hormone agonist
T Var, E Tonguc, M Dogan… - Gynecological …, 2011 - Taylor & Francis
The aim of this study was to evaluate the relationship of oestradiol level on the day of hCG
(peak E2)/oocyte ratio and the outcome of ART cycles. Of the patients who underwent IVF …
(peak E2)/oocyte ratio and the outcome of ART cycles. Of the patients who underwent IVF …
A Randomized Comparison of Two Ovarian Stimulation Protocols with Gonadotropin-Releasing Hormone (GnRH) Antagonist Cotreatment for in Vitro Fertilization …
FP Hohmann, NS Macklon… - The Journal of Clinical …, 2003 - academic.oup.com
Extending the FSH window for multifollicular development by administering FSH from the
midfollicular phase onward constitutes a novel mild protocol for ovarian stimulation for in …
midfollicular phase onward constitutes a novel mild protocol for ovarian stimulation for in …
[PDF][PDF] The impact of LH, E2, and P level of HCG administration day on outcomes of in vitro fertilization in controlled ovarian hyperstimulation
M Wei, XM Zhang, FL Gu, F Lv… - Clin Exp …, 2015 - venus-pro-bucket.s3.amazonaws …
Objectives: The objective of this study was to evaluate the impact of luteinizing hormone
(LH), estradiol (E2) and progesterone (P) levels on the day of human chorionic gonadotropin …
(LH), estradiol (E2) and progesterone (P) levels on the day of human chorionic gonadotropin …
GnRH antagonist versus follicular-phase single-dose GnRH agonist protocol in patients of normal ovarian responses during controlled ovarian stimulation
Y Geng, Y Xun, S Hu, Q Lai, L Jin - Gynecological Endocrinology, 2019 - Taylor & Francis
Objective: This study aims to explore the differences of the ovarian stimulation (OS)
characteristics, laboratory, and clinical outcomes between follicular-phase single-dose …
characteristics, laboratory, and clinical outcomes between follicular-phase single-dose …
The prognostic importance of the number of oocytes retrieved and estradiol levels in poor and normal responders in in vitro fertilization (IVF) treatment
J Dor, DS Seidman, I Ben-Shlomo, D Levran… - Journal of assisted …, 1992 - Springer
A low response to ovarian stimulation in in vitro fertilization poses a unique therapeutic
challenge. Gonadotropin-releasing hormone agonists (GnRHa) have been suggested as a …
challenge. Gonadotropin-releasing hormone agonists (GnRHa) have been suggested as a …
The long protocol of administration of gonadotropin-releasing hormone agonist is superior to the short protocol for ovarian stimulation for in vitro fertilization
SL Tan, C Kingsland, S Campbell, C Mills, J Bradfield… - Fertility and …, 1992 - Elsevier
Objective To investigate whether pituitary desensitization with the gonadotropin-releasing
hormone agonist (GnRH-a), buserelin acetate, before the administration of human …
hormone agonist (GnRH-a), buserelin acetate, before the administration of human …
[HTML][HTML] Ovarian stimulation in in vitro fertilization with or without the “long” gonadotropin-releasing hormone agonist protocol: effect on cycle duration and outcome
R Beloosesky, S Kol, A Lightman, J Itskovitz-Eldor - Fertility and sterility, 2000 - Elsevier
Objective: To study the correlation between stimulation duration of IVF cycles, with and
without GnRH agonist (GnRH-a), and cycle outcome. Design: Retrospective analysis of data …
without GnRH agonist (GnRH-a), and cycle outcome. Design: Retrospective analysis of data …
[HTML][HTML] Ovarian stimulation with daily late follicular phase administration of low-dose human chorionic gonadotropin for in vitro fertilization: a prospective, randomized …
P Serafini, I Yadid, ELA Motta, JR Alegretti… - Fertility and sterility, 2006 - Elsevier
OBJECTIVE: Evaluate the effectiveness of a new ovarian stimulation (OS) protocol before
IVF. DESIGN: Prospective clinical randomized trial. SETTING: Private centers. PATIENT (S) …
IVF. DESIGN: Prospective clinical randomized trial. SETTING: Private centers. PATIENT (S) …